Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D01KAH
|
|||
Former ID |
DNC014521
|
|||
Drug Name |
1-[(3-Methoxybenzyl)amino]ethaniminium chloride
|
|||
Synonyms |
1-[(3-Methoxybenzyl)amino]ethaniminium chloride
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C10H15ClN2O
|
|||
Canonical SMILES |
CC(=NCC1=CC(=CC=C1)OC)N.Cl
|
|||
InChI |
1S/C10H14N2O.ClH/c1-8(11)12-7-9-4-3-5-10(6-9)13-2;/h3-6H,7H2,1-2H3,(H2,11,12);1H
|
|||
InChIKey |
KAHXLIVOQBJXSB-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Nitric-oxide synthase brain (NOS1) | Target Info | Inhibitor | [1] |
BioCyc | Citrulline-nitric oxide cycle | |||
KEGG Pathway | Arginine and proline metabolism | |||
Metabolic pathways | ||||
Calcium signaling pathway | ||||
Phagosome | ||||
Circadian entrainment | ||||
Long-term depression | ||||
Salivary secretion | ||||
Alzheimer's disease | ||||
Amyotrophic lateral sclerosis (ALS) | ||||
NetPath Pathway | EGFR1 Signaling Pathway | |||
Panther Pathway | CCKR signaling map ST | |||
Pathwhiz Pathway | Arginine and Proline Metabolism | |||
Reactome | ROS production in response to bacteria | |||
Nitric oxide stimulates guanylate cyclase | ||||
WikiPathways | Monoamine Transport | |||
Myometrial Relaxation and Contraction Pathways | ||||
Amyotrophic lateral sclerosis (ALS) | ||||
Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis | ||||
Spinal Cord Injury | ||||
Alzheimers Disease | ||||
Effects of Nitric Oxide | ||||
Serotonin Transporter Activity |
References | Top | |||
---|---|---|---|---|
REF 1 | N-Substituted acetamidines and 2-methylimidazole derivatives as selective inhibitors of neuronal nitric oxide synthase. Bioorg Med Chem Lett. 2010 Nov 15;20(22):6495-9. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.